Your course of actions when doctors say 'no.'
All of us experience rejection at some time or another. We try hard and do a good job, but we are told, "Thanks, but no thanks."
What do most of us do when that situation occurs? We often put our tail between our legs, crawl away and think of excuses why they didn't follow our directions, heed our advice or buy our products.
That's the natural response, but it doesn't make us feel any better and it certainly doesn't help promote and sell products.
Let me tell you a story involving my 10-year-old son Craig. He was cut from a "major" baseball team he wanted to join.
I suggested to him that he write the coach a letter thanking him for the opportunity to try out and for all the instruction he received during tryouts.
That evening I came home and found a letter he had written to the coach. He expressed his appreciation for the chance to make the team and wrote that his baseball skills had improved as a result of working with the good players and the coach. He also wished the team and the coach good luck, and promised to cheer for them.
The coach wrote back. He told Craig that in 15 years of coaching, he had never received a letter like that from a player who made the team, let alone from one who had been cut. He told Craig he had class and character and that he was looking forward to Craig trying out the following year.
I tell this story because if a 10-year-old boy can say thanks when the coach says no, then all of us can express gratitude for the chance to show a product or services when a customer says no.
Will it work? Sometimes. I recall a sales representative who called on me for several months and encouraged me to switch from a product I had been using for 15 years to her product. She wrote me several notes thanking me for seeing her and learning about her product. Nearly six months later, she came into my office for a visit and gave me a laminated copy of an informative article. She got my undivided attention, and her kindness and persistence resulted in changing a 15-year prescribing habit.
Another time, a medical manufacturing rep came for a visit. I told him I used his competitor's product and was satisfied with it and with the service. He said that he would be by on a regular basis and would be available if the situation ever changed. After every visit, he sent a note of thanks and promised to come back in a month. After more than a dozen visits, he returned at a time when a need was not being met by his competitor. He got my business. We can learn a lesson from Craig and these sales reps. If everyone said "yes" to every sales presentation, there wouldn't be a need for pharmaceutical representatives.
One way to help ensure a sale is to thank those physicians, members of the formulary committees and pharmacists who say "no". PR
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.